Potential Biomarker May Indicate T-VEC Efficacy
March 18, 2025
A new study from Harvard University and the Massachusetts General Hospital may have uncovered a biomarker indicating a strong response…
The Immunotherapy 360 blog space features articles that encompass prominent issues related to immunotherapy. These are written with the assistance of the staff at AIM at Melanoma, AIM with Immunotherapy and health care practitioners.
If you have an idea for a future article, please reach out to us on our contact page!
